Goal Attainment Scaling in Upper Limb Spasticity Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Rehabilitation Institute, Republic of Slovenia
About this trial
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.
Eligibility criteria
Qualifiers
patient's or caregiver's approval
ischemic or hemorrhagic stroke diagnosed using head CT/MRI
at least one upper limb muscle spasticity (MAS ≥ 3)
candidate for BTX-A treatment or already given BTX-A in the past
Disqualifiers
aphasic patients without caregiver's presence
other neurological or musculoskeletal diseases that could affect the treatment outcome
Trial design
Treatments tested in this trial
- Prescribed exercise program
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov